Federal Bid

Last Updated on 13 Jul 2021 at 6 PM
Solicitation
Tripler army medical center Hawaii

Intercept Platelet Pathogen Reduction Sets

Solicitation ID W81K0221Q0194
Posted Date 13 Jul 2021 at 6 PM
Archive Date 31 Jul 2021 at 4 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office W40m Regional Health Contracting Of
Agency Department Of Defense
Location Tripler army medical center Hawaii United states 96859

The Regional Health Contracting Office – Pacific, in support of Tripler Army Medical Center (TAMC), Hawaii, intends to make a sole source award to Cerus Corporation for the purchase of Cerus Intercept Platelet Pathogen Reduction Sets.  These supplies are the only ones that can meet the Government’s need.  Cerus Corporation is the sole provider of the Cerus Intercept Platelet Pathogen Reduction Sets which uses a chemical agent (amotosalen) that is activated by ultraviolet A (UVA) light to bind nucleic acids so that DNA cannot replicate and thus the cell cannot replicate.  The platelet pathogen reduction sets is used in conjunction with platelets and plasma in an Intercept processing set.  The authority permitting this award without providing full and open competition is cited in FAR 13.106-1(b)(1)(i) which authorizes the government to award contracts when there is only one source available (e.g. urgency, exclusive licensing agreement, brand name or industrial mobilization).

Bid Protests Not Available